Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP238975.RASmxgKkSTLA6hBhQe-9FvKMLNU2-kN3O8mrZMnyOwVBI130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP238975.RASmxgKkSTLA6hBhQe-9FvKMLNU2-kN3O8mrZMnyOwVBI130_assertion type Assertion NP238975.RASmxgKkSTLA6hBhQe-9FvKMLNU2-kN3O8mrZMnyOwVBI130_head.
- NP238975.RASmxgKkSTLA6hBhQe-9FvKMLNU2-kN3O8mrZMnyOwVBI130_assertion description "[Eighty-six percent of our patients present either HLA-DR5 or the beta DR-2.9-kb-EcoRI allogenotope or lack the C4-14.3-kb-EcoRI allogenotope compared to 48% in controls; however, these particular DR and C4 RFLPs may not represent the corresponding DRB1 or C4 genes but rather neighboring ones which may be relevant to confer JRA susceptibility.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP238975.RASmxgKkSTLA6hBhQe-9FvKMLNU2-kN3O8mrZMnyOwVBI130_provenance.
- NP238975.RASmxgKkSTLA6hBhQe-9FvKMLNU2-kN3O8mrZMnyOwVBI130_assertion evidence source_evidence_literature NP238975.RASmxgKkSTLA6hBhQe-9FvKMLNU2-kN3O8mrZMnyOwVBI130_provenance.
- NP238975.RASmxgKkSTLA6hBhQe-9FvKMLNU2-kN3O8mrZMnyOwVBI130_assertion SIO_000772 1972672 NP238975.RASmxgKkSTLA6hBhQe-9FvKMLNU2-kN3O8mrZMnyOwVBI130_provenance.
- NP238975.RASmxgKkSTLA6hBhQe-9FvKMLNU2-kN3O8mrZMnyOwVBI130_assertion wasDerivedFrom befree-20140225 NP238975.RASmxgKkSTLA6hBhQe-9FvKMLNU2-kN3O8mrZMnyOwVBI130_provenance.
- NP238975.RASmxgKkSTLA6hBhQe-9FvKMLNU2-kN3O8mrZMnyOwVBI130_assertion wasGeneratedBy ECO_0000203 NP238975.RASmxgKkSTLA6hBhQe-9FvKMLNU2-kN3O8mrZMnyOwVBI130_provenance.